Related references
Note: Only part of the references are listed.Demographic and clinical predictors of multiple intracranial aneurysms in patients with subarachnoid hemorrhage
Michael M. McDowell et al.
JOURNAL OF NEUROSURGERY (2018)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Role of Microglia and T Cells in Different Grades of Meningioma
Margaret Holmes et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2017)
PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer
Benjamin A. Kansy et al.
CANCER RESEARCH (2017)
First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation
Ramita Dewan et al.
BMC CANCER (2017)
Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma
Seunggu J. Han et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer
M. Miyan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Rekindling cancer vaccines
Malorye Allison Branca
NATURE BIOTECHNOLOGY (2016)
Tumor infiltrating lymphocytes in ovarian cancer
Phillip P. Santoiemma et al.
CANCER BIOLOGY & THERAPY (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma
Ziming Du et al.
ONCOTARGET (2015)
Immunosuppressive mechanisms of malignant gliomas: parallels at non-CNS sites
Powell Perng et al.
FRONTIERS IN ONCOLOGY (2015)
Prognostic Value of Tumor-Infiltrating FoxP3+ T Cells in Gastrointestinal Cancers: A Meta Analysis
Yong Huang et al.
PLOS ONE (2014)
Roles of Tregs in development of hepatocellular carcinoma: A meta-analysis
Hong-Qiang Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
A Circulating Subpopulation of Monocytic Myeloid-Derived Suppressor Cells as an Independent Prognostic/Predictive Factor in Untreated Non-Small Lung Cancer Patients
Eleni-Kyriaki Vetsika et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1
Ian M. Zitron et al.
CANCER BIOLOGY & THERAPY (2013)
Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients
Ang Huang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages
Orin Bloch et al.
CLINICAL CANCER RESEARCH (2013)
CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
Patrick A. Ott et al.
CLINICAL CANCER RESEARCH (2013)
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
Priscilla K. Brastianos et al.
NATURE GENETICS (2013)
Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma
Hiromi Kanno et al.
NEURO-ONCOLOGY (2013)
The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells
Liangjuan Fang et al.
NEURO-ONCOLOGY (2013)
Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO
Victoria E. Clark et al.
SCIENCE (2013)
CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
Brad H. Nelson
JOURNAL OF IMMUNOLOGY (2010)
PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo
Shunsuke Chikuma et al.
JOURNAL OF IMMUNOLOGY (2009)
Share Paper
